publication . Other literature type . Article . 2009

Adverse effects of anticancer agents that target the VEGF pathway

Name: Adverse effects of anticancer agents that target the VEGF pathway
Keywords: Oncology

Jessica N. Cleck; Helen X. Chen;

Open Access

Published: 07 Jul 2009

Publisher: Springer Science and Business Media LLC

Summary

Abstract

Antiangiogenic agents that target the VEGF pathway have become an important part of standard therapy in multiple cancer indications. Although most adverse effects of VEGF inhibitors are modest and manageable, some are associated with serious and life-threatening consequences. This Review examines the toxicity profiles of anti-VEGF monoclonal antibodies and small-molecule inhibitors and considers the potential mechanisms of the adverse effects, risk factors, and the implications for patient management. Antiangiogenesis agents that target the VEGF/VEGF receptor pathway have become an important part of standard therapy in multiple cancer indications. With expanded ...

doi: 10.1038/nrclinonc.2009.94

Subjects

free text keywords: Oncology, Bioinformatics, Sunitinib, medicine.drug, medicine, Monoclonal, Vegf pathway, Toxicity, Pharmacology, Monoclonal antibody, medicine.drug_class, Bevacizumab, Adverse effect, Sorafenib, business.industry, business

Download fromView all 3 versions